Khiron Pharma Commerce ApS: Financial statements 2017
CVR: 37003204
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Khiron Pharma Commerce ApS (CVR 37003204) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 240,443 and a net result of DKK 50,070. Equity in the 2017 report amounted to DKK 32,431. The solvency ratio was 47.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 240,443
- Profit/Loss
- DKK 50,070
- Equity
- DKK 32,431
- Total Assets
- DKK 68,348
- Employees
- 1
Official annual report
Keep an eye on Khiron Pharma Commerce ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Khiron Pharma Commerce ApS has published its interim report for the period August 10, 2015 – December 31, 2016.
As of May 24, 2017, TREKRONER REVISION A/S - GODKENDTE REVISORER has stepped down as auditor of Khiron Pharma Commerce ApS.
About Khiron Pharma Commerce ApS
Khiron Pharma Commerce ApS is a Danish company of the type Anpartsselskab based in Frederiksværk, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Dan Henning Norden and Lone Lindquist-Nielsen. The company's owners include Lone Lindquist-Nielsen, Dan Henning Norden and Mette Rokkedal. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 780,426 and a net result of DKK 339,637 compared with DKK 4,240 the year before. Equity in the 2025 report amounted to DKK 515,211.